Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain LGND message board posts where the ticker symbol LGND has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest LGND SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-017610 Size: 7 KB
2018-06-21
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-017609 Size: 7 KB
2018-06-21
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-017608 Size: 7 KB
2018-06-21
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-017604 Size: 9 KB
2018-06-21
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-017603 Size: 7 KB
2018-06-21
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-017599 Size: 7 KB
2018-06-21
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001104659-18-041511 Size: 9 KB
2018-06-21
8-K  Documents Current report, item 5.07
Acc-no: 0000886163-18-000082 (34 Act)  Size: 69 KB
2018-06-19 001-33093
18907139
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000886163-18-000080 Size: 8 KB
2018-06-04
DEFA14A  Documents Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Acc-no: 0001193125-18-182414 (34 Act)  Size: 402 KB
2018-06-04 001-33093
18876783
More LGND SEC Filings


Related news from
Fri, 15 Jun 2018
11:30:00 +0000
3 Biotech Stocks Up in the Past Month on Industry Turnaround
After a strong start in 2018, the drug sector struggled a bit in the next few months probably on U.S. market instability and a few negative updates on the pipeline and regulatory front. In the first four months of the year (January-April), the biotech industry significantly underperformed the S&P 500. The biotech industry declined 9.3% compared with the S&P 500’s decline of 0.8%.
Fri, 08 Jun 2018
12:07:13 +0000
See what the IHS Markit Score report has to say about Ligand Pharmaceuticals Inc.
Ligand Pharmaceuticals Inc NASDAQ NMS:LGND
Mon, 04 Jun 2018
13:41:01 +0000
The Zacks Analyst Blog Highlights: Illumina, Athersys, EyePoint Pharmaceuticals, Rhythm Pharmaceuticals and Ligand Pharmaceuticals
The Zacks Analyst Blog Highlights: Illumina, Athersys, EyePoint Pharmaceuticals, Rhythm Pharmaceuticals and Ligand Pharmaceuticals
Fri, 01 Jun 2018
21:08:09 +0000
Kitov (KTOV) Gets Approval from FDA for Consensi, Shares Up
Kitov Pharma (KTOV) gained as the FDA approved Consensi (amlodipine and celecoxib) oral tablets for the treatment of osteoarthritis pain and hypertension.
Fri, 01 Jun 2018
12:42:12 +0000
"Right To Try" Brings Good News for Biotech Sector: 5 Picks
Passage of the Right To Try law and WHO's focus on assessing the quality of bio-similar drugs is expected to benefit biotech stocks.
Thu, 31 May 2018
20:56:08 +0000
Catalyst's Fridapse Gets Priority Review by FDA, Shares Up
The FDA grants Priority Review to Catalyst's (CPRX) lead pipeline candidate, Firdapse, and set an action date of Nov 28, 2018.
Thu, 31 May 2018
15:23:00 +0000
5 Biotech Stocks to Boost Your Portfolio’s Health This Year
Also, a slowdown in sales of some of the most high-profile older drugs, courtesy of payers and competitive pressure from both branded and generic drugs, is a concern for the sector. Drug pricing has been in the spotlight once again this month when President Donald Trump announced plans to lower prescription drug costs.
Wed, 30 May 2018
14:39:02 +0000
Allergan Recalls Taytulla Oral Contraceptives, Stock Down
Allergan (AGN) recalls some sample packs of Taytulla oral birth control pills. Shares decline.
Tue, 29 May 2018
21:45:09 +0000
Bayer's Generic Competition, Pipeline Setback Issues Remain
Generic threats/competition for many of its products remain a concern for Bayer (BAYRY).
Mon, 28 May 2018
12:21:12 +0000
Prothena Restructures Resources, to Cut Workforce by 57%
Prothena announces a reduction in workforce by 57%, due to the discontinuation of lead program, NEOD001.
Fri, 25 May 2018
13:24:01 +0000
AbbVie's Imbruvica's Phase III Study Meets Primary Endpoint
AbbVie's (ABBV) phase III iLLUMINA study evaluating Imbruvica in combination with Gazyva meets its primary endpoint of improvement in progression-free survival.
Thu, 24 May 2018
15:18:03 +0000
SWTUY or LGND: Which Is the Better Value Stock Right Now?
SWTUY vs. LGND: Which Stock Is the Better Value Option?
Wed, 23 May 2018
19:05:07 +0000
Dr. Reddy's (RDY) Q4 Earnings Fall, Revenues Decline Y/Y
Dr. Reddy's bottom line and top line suffered a year-over-year decline, in the fourth quarter of fiscal 2018.
Wed, 23 May 2018
14:51:02 +0000
Allergan Stock Down Since Q1 Earnings Report: Here's Why
Though Allergan (AGN) boasts a solid underlying business, its stock is down. Here we discuss why.
Tue, 22 May 2018
16:01:04 +0000
Inovio Initiates Phase II Study on Pipeline Drug VGX-3100
Inovio (INO) begins a phase II study to evaluate the efficacy of its pipeline candidate VGX-3100 on adult men and women with human papilloma virus (HPV)-related anal dysplasia.
Mon, 21 May 2018
15:09:03 +0000
AstraZeneca's Lokelma Gains FDA Nod to Treat Hyperkalemia
AstraZeneca's (AZN) Lokelma secures an FDA approval for the treatment of hyperkalemia in adults.
Mon, 21 May 2018
12:44:12 +0000
Ligand Pharmaceuticals (LGND) Hits a 52-Week High, Can the Run Continue?
Ligand Pharmaceuticals Incorporated is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for LGND for clues.
Fri, 18 May 2018
19:21:07 +0000
Pfizer's Epilepsy Drug Lyrica Succeeds in Pediatric Study
Pfizer (PFE) announces positive top-line results from a phase III study in pediatric epilepsy wherein Lyrica Oral Solution CV meets its primary endpoint.
Fri, 18 May 2018
14:06:02 +0000
AstraZeneca's (AZN) Q1 Earnings & Sales Miss, Stock Down
AstraZeneca (AZN) misses earnings and sales estimates in the first quarter. It maintains its previously issued outlook for 2018.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "ValueForum is the gold standard, valuable because of the exceptional people who post here, and because the best of them are candid, detailed and informed. There is little tolerance for the b.s. found on public boards, and management and members are vigilant and aggressive about TOS violations. VF is the gold standard." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards